YOUR BUSINESS AUTHORITY
Springfield, MO
Novartis AG penned a $9.7 billion purchase deal for Medicines Co.
Bloomberg reports the acquisition focuses mostly on a single treatment: experimental cholesterol drug inclisiran.
Similarly, last year Novartis gained muscle disease gene therapy Zolgensma by buying drugmaker AveXis Inc. for $8.7 billion.
Read more from Bloomberg.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year